APS — Aptose Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Aptose Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	79.1	47	9.25	6.15	0.935
Prepaid Expenses
Total Other Current Assets
Total Current Assets	81.7	49.5	11.9	9.53	6.45
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.788	1.51	1.09	0.597	0.179
Other Long Term Assets
Total Assets	82.5	51	13	10.1	10
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	8.17	12.3	15.3	4.46	9.31
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	8.29	13.3	15.9	14.7	37.2
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	74.2	37.7	-2.9	-4.54	-27.2
Total Liabilities & Shareholders' Equity	82.5	51	13	10.1	10
Total Common Shares Outstanding